Form SEC STAFF LETTER - SEC Staff Letter: REDACTED EXHIBIT
SEC Accession No. 9999999997-21-003338
Filing Date
2021-06-07
Accepted
2021-06-10 13:14:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf REDACTED EXHIBIT 197175
  Complete submission text file 9999999997-21-003338.txt   272554
Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

EIN.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SEC STAFF LETTER
SIC: 2834 Pharmaceutical Preparations